MPs have raised serious concerns over NHS England’s decision to give Palantir access to identifiable patient data. The move is seen as risky and could undermine public trust in how sensitive health information is handled. Critics worry that allowing a US tech company such broad access might compromise patient privacy and security. NHS Data Access